EKF Diagnostics (LON:EKF) Share Price Passes Above 200 Day Moving Average – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 25.49 and traded as high as GBX 27. EKF Diagnostics shares last traded at GBX 27, with a volume of 458,312 shares changing hands.

Wall Street Analyst Weigh In

Separately, Stifel Nicolaus reaffirmed a “buy” rating and issued a GBX 35 price objective on shares of EKF Diagnostics in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of GBX 35.

EKF Diagnostics Stock Performance

The company has a current ratio of 4.16, a quick ratio of 1.77 and a debt-to-equity ratio of 2.01. The firm’s fifty day moving average is GBX 26.05 and its 200 day moving average is GBX 25.49. The company has a market cap of £116.24 million, a PE ratio of 57.45 and a beta of 0.52.

EKF Diagnostics (LON:EKF) last announced its earnings results on Tuesday, March 24th. The company reported GBX 0.47 earnings per share (EPS) for the quarter. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%. As a group, research analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.